ABI Hinged VisiGen Deal on SeqWright s Scientific Chops, Not Investment; ABI Continues Fishing | GenomeWeb

NEW YORK, Nov. 7 (GenomeWeb News) - In sports, players sometimes negotiate to land on teams with the best-skilled players in hopes of improving their chances of winning a championship. This same reasoning is what seems to have led Applied Biosystems to hinge a pending partnership with VisiGen Biotechnologies on SeqWright.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.